Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030440 | SCV000053109 | benign | Cardiomyopathy | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Laboratory for Molecular Medicine, |
RCV000041622 | SCV000065318 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Gly1406Gly in Exon 23 of SCN5A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence and has been identified in 1.3% (88/6832) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs41311123). |
Gene |
RCV000041622 | SCV000171574 | benign | not specified | 2011-07-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000713142 | SCV000252895 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041622 | SCV000306546 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000246331 | SCV000318423 | benign | Cardiovascular phenotype | 2015-06-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000713142 | SCV000843719 | benign | not provided | 2018-03-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841548 | SCV000910617 | benign | Cardiac arrhythmia | 2018-03-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000713142 | SCV001159249 | benign | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001146496 | SCV001307245 | benign | Brugada syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001146497 | SCV001307246 | benign | Dilated cardiomyopathy 1E | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001146498 | SCV001307247 | benign | Long QT syndrome 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001146499 | SCV001307248 | benign | Sick sinus syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001149266 | SCV001310210 | likely benign | Ventricular fibrillation, paroxysmal familial, type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001149267 | SCV001310211 | uncertain significance | Progressive familial heart block, type 1A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000713142 | SCV003916428 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SCN5A: BP4, BP7, BS1, BS2 |
CHEO Genetics Diagnostic Laboratory, |
RCV000030440 | SCV004239672 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000713142 | SCV001740927 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041622 | SCV001922373 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041622 | SCV001931331 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041622 | SCV001954887 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041622 | SCV001975829 | benign | not specified | no assertion criteria provided | clinical testing | ||
Molecular Genetics Laboratory, |
RCV001082798 | SCV002029178 | likely benign | Brugada syndrome | 2021-06-22 | no assertion criteria provided | clinical testing |